Skip to main content
SpringerLink
Log in

Vitamins and Minerals in the Treatment of Acne Vulgaris

  • Chapter
  • First Online:
Integrative Dermatology

  • 825 Accesses

Abstract

The complicated and multifactorial nature of acne pathophysiology provides a multitude of opportunities for vitamins and minerals to disrupt the inflammatory cascade. In their traditional roles as dietary necessities, vitamins and minerals participate in keratinocyte proliferation and maturation, modulation of lipid production in human sebocytes, and inhibition of pro-inflammatory cytokines, matrix metalloproteinases, and antimicrobial peptides, as well as act as antioxidants. Not surprisingly, then, there is considerable in vitro and preclinical data predicting their efficacy in acne. Although conclusive clinical evidence is currently lacking for many of them, more vigorous trials are being conducted with increasingly convincing in vivo data. At this time, data for vitamin A analogs, zinc, and niacinamide is most compelling. It may well be that combination therapy will be more efficacious than monotherapy. Fortunately, due to their large safety margin, we can afford to be generous with our recommendations while awaiting more definitive results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol. 2008;9(6):369–81.

    Article  PubMed  Google Scholar 

  2. Czernielewski J, Michel S. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15(Suppl 3):5–12.

    Article  PubMed  Google Scholar 

  3. Tenaud I, Khammari A. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol. 2007;16:500–6.

    Article  CAS  PubMed  Google Scholar 

  4. Olson J, Shah N. Vitamin A toxicity. Available at: www.ncbi.nlm.nih.gov. Accessed 4 December 2019.

  5. Hunt J. Teratogenicity of high vitamin A intake. N Engl J Med. 1996;334(18):1197.

    CAS  PubMed  Google Scholar 

  6. Vanchinathan V, Lim H. A dermatologist’s perspective on vitamin D. Mayo Clin Proc. 2012;87:372–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mostafa WZ, Hegazy RA. Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res. 2015;6(6):793–804.

    Article  CAS  PubMed  Google Scholar 

  8. Amson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137–42.

    Article  CAS  Google Scholar 

  9. Kostoglou-Athanassious I, Athanassious P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012;3:181–7.

    Article  CAS  Google Scholar 

  10. Cheng H, Kim S, Park G, Chang SE, Bang S, Won CH, et al. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol. 2014;133:1048–55.

    Article  CAS  PubMed  Google Scholar 

  11. Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, Beltrami G, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166:505–10.

    Article  CAS  PubMed  Google Scholar 

  12. Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010;62:937–41.

    Article  CAS  PubMed  Google Scholar 

  13. Aksu Cerman A, Sarikaya Solak S, Kivanc AI. Vitamin D deficiency in alopecia areata. Br J Dermatol. 2014;170:1299–304.

    Article  CAS  PubMed  Google Scholar 

  14. Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, Tristan GR, et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by Vitamin A and Vitamin D. J Invest Dermatol. 2014;134:366–73.

    Article  CAS  PubMed  Google Scholar 

  15. Reichrath J, Schuler C, Seifert M, et al. The vitamin D endocrine system of human sebocytes. Exp Dermatol. 28 June 2008. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0625.2006.00439b.x.

  16. Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117:803–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lee WJ, Choi YH, Sohn MY, Lee SJ, Kim DW. Expression of inflammatory biomarkers from cultured sebocytes was influenced by treatment with vitamin D. Indian J Dermatol. 2013;58:327.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lim SK, Ha JM, Lee Y, Lee Y, Seo YJ, Kim CD, et al. Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial. PLoS One. 2016;11(8):e0161162.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Stewart T, Bazergy C. Hormonal and dietary factors in acne vulgaris vs. controls. Dermatoendocrinol. 2018;10(1):e1442160.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Yildizgoren M, Togral A. Preliminary evidence for vitamin D deficiency in nodulocystic acne vulgaris. Dermatoendocrinol. 2014;6(1):e983687.

    Article  PubMed  Google Scholar 

  21. Toossi P, Azizian Z, Yavari H, Fakhim TH, Amini SH, Enamzade R. Serum 25-hydroxy vitamin D levels in patients with acne vulgaris and its association with disease severity. Clin Cases Miner Bone Metab. 2015;12(3):238–42.

    PubMed  PubMed Central  Google Scholar 

  22. Al-Taiar A, AlKabbaz M, Rahman A, Al-Sabah R, Shaban L, Akhtar S. Plasma 25-hydroxy vitamin D is not associated with acne vulgaris. Nutrients. 2018;10(10):E1525.

    Article  PubMed  CAS  Google Scholar 

  23. Jarosz A, El-Sohemy A. Association between vitamin D status and premenstrual syndrome. J Acad Nutr Diet. 2019;119(1):115–23.

    Article  PubMed  Google Scholar 

  24. Lee WJ, Kim SL, Choe YS, Jang YH, Lee SJ, Kim DW. Magnesium ascorbyl phosphate regulates the expression of inflammatory biomarkers in cultured sebocytes. Ann Dermatol. 2015;27(4):376–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001;116:853–9.

    Article  CAS  PubMed  Google Scholar 

  26. Farue M, Kadano T. Inflammatory skin march in atopic dermatitis and psoriasis. Inflamm Res. 2017;66(10):838–42.

    Google Scholar 

  27. Yamamoto A, Takenovichi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995;287:214–8.

    Article  CAS  PubMed  Google Scholar 

  28. Liu J, Yan R, Zhong Q, Ngo S, Bangayan NJ, Nguyen L, et al. The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. ISME J. 2015;9(9):2078–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Coughlin CC, Swink SM, Horwinski J, Sfyroera G, Bugayev J, Grice EA, et al. The preadolescent acne microbiome: a prospective, randomized, pilot study investigating characterization and effects of acne therapy. Pediatr Dermatol. 2017;34(6):661–4.

    Article  PubMed  Google Scholar 

  30. Kelhala HL, Aho VTE, Fyhrquist N, Pereira PAB, Kubin ME, Paulin L, et al. Isotretinoin and lymecycline treatments modify the skin microbiota in acne. Exp Dermatol. 2018;27(1):30–6.

    Article  PubMed  CAS  Google Scholar 

  31. McCoy WH 4th, Otchere E, Rosa BA, Martin J, Mann CM, Mitreva M. Skin ecology during sebaceous drought. How skin microbes respond to isotretinoin. J Invest Dermatol. 2019;139:732–5.

    Article  CAS  PubMed  Google Scholar 

  32. Shin J, Kim YJ, Kwon O, Kim NI, Cho Y. Associations among plasma vitamin C, epidermal ceramide and clinical severity of atopic dermatitis. Nutr Res Pract. 2016;10:398–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Khan H, Akhtar N, Ali A. Assessment of compound ascorbyl palmitate (AD) and sodium ascorbyl phosphate (SAP) on facial skin sebum control in female healthy volunteers. Drug Res (Stuttg). 2017;67(1):52–8.

    CAS  Google Scholar 

  34. Pinnell S. Cutaneous photodamage, oxidative stress and topical antioxidant protection. J Am Acad Dermatol. 2003;48:1–22.

    Article  PubMed  Google Scholar 

  35. Kosari P, Alikhan A, Sockolov M, Feldman SR. Vitamin E and allergic contact dermatitis. Dermatitis. 2010;21(3):148–53.

    Article  CAS  PubMed  Google Scholar 

  36. Ozuguz P, Dogruk Kacar S, Ekiz O, Takci Z, Balta I, Kalkan G. Evaluation of serum vitamins A and E and zinc levels according to the severity of acne vulgaris. Cutan Ocul Toxicol. 2014;33(2):99–102.

    Article  CAS  PubMed  Google Scholar 

  37. Valacchi G, Rimbach G, Salion C, et al. Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology. 2001;165(2–3):22–34.

    Google Scholar 

  38. Rota C, Tomasi A, Iannone A. Alpha-tocopherol amplifies benzoyl peroxide free radical decomposition in a chemical system. Free Radic Res. 2006;40(6):637–45.

    Article  CAS  PubMed  Google Scholar 

  39. Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, et al. Safety of high-dose nicotinamide: a review. Diabetologia. 2000;43:1337–45.

    Article  CAS  PubMed  Google Scholar 

  40. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462–70.

    Article  CAS  PubMed  Google Scholar 

  41. Namazi MR. Nicotinamide: a potential addition to the anti-psoriatic weaponry. FASEB J. 2003;17(11):1377–9.

    Article  CAS  PubMed  Google Scholar 

  42. Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 1994;130(6):753–8.

    Article  CAS  PubMed  Google Scholar 

  43. Navarette-Solis J, Castanedo-Cazaras J, Torres-Alvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;379173:2011.

    Google Scholar 

  44. Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618–26.

    Article  CAS  PubMed  Google Scholar 

  45. Grange PA, Raingeaud J, Calvez V, Dupin N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 2009;56:106–12.

    Article  CAS  PubMed  Google Scholar 

  46. Wohlrab J, Kreft D. Niacinamide – mechanisms of action and its topical use in dermatology. Skin Pharmacol Physiol. 2014;27:311–5.

    Article  CAS  PubMed  Google Scholar 

  47. Draelos Z, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. J Cosmet Laser Ther. 2006;8:96–101.

    Article  PubMed  Google Scholar 

  48. Fivenson DP. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. Cutis. 2006;77:5–10.

    PubMed  Google Scholar 

  49. Walocko FM, Eber AE, Keri JE, Al-Harbi MA, Nouri K. The role of nicotinamide in acne treatment. Dermatol Ther. 2017;30(5):e12481. https://doi.org/10.1111/dth.12481. Epub 2017 Feb 21.

    Article  Google Scholar 

  50. Khodaeiani E, Fouladi RF, Amirnia M, Saeidi M, Karimi ER. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. Int J Dermatol. 2013;52:999–1004.

    Article  CAS  PubMed  Google Scholar 

  51. Shahmoradi Z, Iragi F, Siadat AH, Ghorbaini A. Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: a double-blinded randomized clinical trial. J Res Med Sci. 2013;18:115–7.

    PubMed  PubMed Central  Google Scholar 

  52. Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34:434–7.

    Article  CAS  PubMed  Google Scholar 

  53. Kaymak Y, Onder M. An investigation of efficacy of topical niacinamide for the treatment of mild and moderate acne vulgaris. J Turk Acad Dermatol. 2008;2(4):jtad82402a. Available at: http://www.jtad.org/2008/4/jtad82402a.pdf.

    Google Scholar 

  54. Dos SK, Barbhuiya JN, Jana S, Dey SK. Comparative evaluation of clindamycin phosphate 1% and clindamycin phosphate 1% with nicotinamide gel 4% in the treatment of acne vulgaris. Indian J Dermatol Venereol Leprol. 2003;69:8–9.

    CAS  PubMed  Google Scholar 

  55. Sardesai V, Kambli V. Comparison of efficacy of topical clindamycin and nicotinamide combination with plain clindamycin for the treatment of acne vulgaris and acne resistant to topical antibiotics. Indian J Dermatol Venereol Leprol. 2003;69:138–9.

    CAS  PubMed  Google Scholar 

  56. Morganti P, Berardesca E, Guarneri B, Guarneri F, Fabrizi G, Palombo P, et al. Topical clindamycin 1% vs linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial. Int J Cosmet Sci. 2011;33:467–76.

    Article  CAS  PubMed  Google Scholar 

  57. Emanuele E, Bertona M, Altabas K, Altabas V, Alessandrini G. Anti-inflammatory effects of topical preparation containing nicotinamide, retinol, and 7-dehydrocholesterol in patients with acne: a gene expression study. Clin Cosmet Investig Dermatol. 2012;5:33–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Niren N, Torok H. The nicomide improvement inclinical outcomes study (NICOS): results of an 8-week trial. Cutis. 2006;77:17–28.

    PubMed  Google Scholar 

  59. Shalita AR, Falcon R, Olansky A, Iannotta P, Akhavan A, Day D, et al. Inflammatory acne management with a novel prescription dietary supplement. J Drugs Dermatol. 2012;11:1428–33.

    CAS  PubMed  Google Scholar 

  60. Jadassohn W, Paillard R, Hofer R, et al. Vitamin B12 et poussee aceneiforme. Dermatologica. 1958;116:349. In French.

    Google Scholar 

  61. Puissant A, Vanbremeersch F, Monfort J, Lamberton JN. A new iatrogenic dermatosis: acne caused by vitamin B 12. Bull Soc Fr Dermatol Syphiligr. 1967;74:813–5. In French.

    CAS  PubMed  Google Scholar 

  62. Braun-Falco O, Lincke H. The problem of vitamin B6/B12 acne. A contribution on acne medicamentosa (author’s transl). MMW Munch Med Wochenschr. 1976;118:155–60. In German.

    CAS  PubMed  Google Scholar 

  63. Dupre A, Albarel N, Bonafe JL, Christol B, Lassere J. Vitamin B-12 induced acnes. Cutis. 1979;24:210–1.

    CAS  PubMed  Google Scholar 

  64. Sherertz E. Acneiform eruption due to “megadose” vitamins B6 and B12. Cutis. 1991;48:119.

    CAS  PubMed  Google Scholar 

  65. Balta I, Ozuguz P. Vitamin B12-induced acneiform eruption. Cutan Ocul Toxicol. 2014;33:94–5.

    Article  PubMed  Google Scholar 

  66. Goldblatt S. Vitamin B-12 levels in blood serum in acne-like skin diseases. Hautarzt. 1966;17:106–8. In German.

    CAS  PubMed  Google Scholar 

  67. Karadag AS, Tutal E, Ertugrul DT, Akin KO. Effect of isotretinoin treatment on plasma holotranscobalamin, vitamin B12, folic acid, and homocysteine levels: non-controlled study. Int J Dermatol. 2011;50:1564–9.

    Article  CAS  PubMed  Google Scholar 

  68. Kang D, Shi B, Erfe MC, Craft N, Li H. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci Transl Med. 2015;7(293):293ra103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, et al. The primary transcriptome for the major human pathogen Helicobacter pylori. Nature. 2010;464:250–5.

    Article  CAS  PubMed  Google Scholar 

  70. Lundrigan M, Kadner R. Altered cobalamin metabolism in Escherichia coli btuR mutants affects btuB gene regulation. J Bacteriol. 1989;171:154–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Piomelli S, Davidow B, Guinee VF, Young P, Gay G. The FEP (free erythrocyte porphyrins) test: a screening micromethod for lead poisoning. Pediatrics. 1973;51:254–9.

    Article  CAS  PubMed  Google Scholar 

  72. Cervantes J, Eber AE, Perper M, Nascimento VM, Nouri K, Keri JE. The role of zinc in the treatment of acne: a review of the literature. Dermatol Ther. 2018;31(1):e12576. https://doi.org/10.1111/dth.12576.

    Article  Google Scholar 

  73. Sanstead H. Understanding zinc: recent observations and interpretation. J Lab Clin Med. 1994;124:322–7.

    Google Scholar 

  74. Solomons N. Mild human zinc deficiency produces an imbalance between cell-mediated and humoral immunity. Nutr Rev. 1998;56:27–8.

    Article  CAS  PubMed  Google Scholar 

  75. Prasad A. Zinc: an overview. Nutrition. 1995;11:93–9.

    CAS  PubMed  Google Scholar 

  76. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA. 1990;264:1441–3.

    Article  CAS  PubMed  Google Scholar 

  77. Willis MS, Monaghan SA, Miller ML, McKenna RW, Perkins WD, Levinson BS, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. 2005;123:125–31.

    Article  PubMed  Google Scholar 

  78. Duncan A, Yacoubian C, Watson N, Morrison I. The risk of copper deficiency in patients prescribed zinc supplements. J Clin Pathol. 2015;68(9):723–5.

    Article  CAS  PubMed  Google Scholar 

  79. Lomaestro B, Bailae G. Absorption interactions with fluoroquinolones. 1995 update. Drug Saf. 1995;12:314–33.

    Article  CAS  PubMed  Google Scholar 

  80. Penttila O, Hurme H, Neuvonen P. Effect of zinc sulfate on the absorption of tetracycline and doxycycline in man. Eur J Clin Pharmacol. 1975;9:131–4.

    Article  CAS  PubMed  Google Scholar 

  81. Webster P. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand. 1980;208:209–12.

    Article  Google Scholar 

  82. Fitzherbert J. Zinc deficiency in acne vulgaris. Med J Aust. 1977;2:685–6.

    Article  CAS  PubMed  Google Scholar 

  83. Michaelsson G, Vahlquist A, Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol. 1977;96:283–6.

    Article  CAS  PubMed  Google Scholar 

  84. Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121.

    Article  PubMed  Google Scholar 

  85. Chow SC. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases. Arch Immunol Ther Exp. 2009;57:243–51.

    Article  CAS  Google Scholar 

  86. Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709152.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T, et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol. 2006;7:971–7.

    Article  CAS  PubMed  Google Scholar 

  88. Sardana K, Chugh S, Garg V. The role of zinc in acne and prevention or resistance: have we missed the “base” effects. Int J Dermatol. 2014;53:125–7.

    Article  PubMed  Google Scholar 

  89. Sugimoto Y, Lopez-Solache I, Labrie F, Luu-The V. Cations inhibit specifically type 1 5 alpha-reductase found in human skin. J Invest Dermatol. 1995;104:775–8.

    Article  CAS  PubMed  Google Scholar 

  90. Bae J, Park S. Evaluation of antimicrobial activity of zinc oxide, citric acid and a mix of both against Propionibacterium acnes. Int J Cosmet Sci. 2016;38(6):550–7.

    Article  CAS  PubMed  Google Scholar 

  91. Cochran R, Tucker S, Flannigan S. Topical zinc therapy for acne vulgaris. Int J Dermatol. 1985;24:188–90.

    Article  CAS  PubMed  Google Scholar 

  92. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69:541–3.

    CAS  PubMed  Google Scholar 

  93. Dreno B, Floulc P, Reynaud A, Moyse D, Habert H, Richet H. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol. 2005;15:152–5.

    CAS  PubMed  Google Scholar 

  94. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. 1978;58:443–8.

    CAS  PubMed  Google Scholar 

  95. Hillström L, Pettersson L, Hellbe L, Kjellin A, Leczinsky CG, Nordwall C. Comparison of oral treatment with zinc sulfate and placebo in acne vulgaris. Br J Dermatol. 1977;97:681–4.

    Article  PubMed  Google Scholar 

  96. Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobate with oral zinc. Br J Dermatol. 1999;141:1137–8.

    Article  CAS  PubMed  Google Scholar 

  97. Meynadier J. Efficacy and safety study of two zinc gluconate regiments in the treatment of inflammatory acne. Eur J Dermatol. 2000;10:269–73.

    CAS  PubMed  Google Scholar 

  98. Orris L, Shalita A, Sibulkin D, London SJ, Gans EH. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol. 1978;114:1018–20.

    Article  CAS  PubMed  Google Scholar 

  99. Verma K, Saini A, Dhamija S. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60:337–40.

    CAS  PubMed  Google Scholar 

  100. Weimar VM, Puhl SC, Smith WH, tenBroeke JE. Xinc sulfate in acne vulgaris. Arch Dermatol. 1978;114:1776–8.

    Article  CAS  PubMed  Google Scholar 

  101. Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol. 1977;57:357–60.

    CAS  PubMed  Google Scholar 

  102. Capitanio B, Sinagra JL, Weller RB, Brown C, Berardesca E. Randomized controlled study of a cosmetic treatment for mild acne. Clin Exp Dermatol. 2012;37:346–9.

    Article  CAS  PubMed  Google Scholar 

  103. Fluhr JW, Bosch B, Gloor M, Höffler U. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. Zentralbl Bakteriol. 1999;289:445–56.

    Article  CAS  PubMed  Google Scholar 

  104. Sardana K, Garg V. An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris. Dermatol Ther. 2010;23:411–8.

    Article  PubMed  Google Scholar 

  105. Schachner L, Eaglstein W, Kittles C, Mertz P. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol. 1990;22:253–60.

    Article  CAS  PubMed  Google Scholar 

  106. Strauss JS, Stranieri AM. Acne treatment with topical erythromycin and zinc: effect of propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol. 1984;11:86–9.

    Article  CAS  PubMed  Google Scholar 

  107. Bojar RA, Eady EA, Jones CE, Cunliffe WJ, Holland KT. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol. 1994;130:329–36.

    Article  CAS  PubMed  Google Scholar 

  108. Chu A, Huber F, Plott R. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol. 1997;136:235–8.

    Article  CAS  PubMed  Google Scholar 

  109. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol. 1979;101:321–5.

    Article  CAS  PubMed  Google Scholar 

  110. Cunliffe WJ, Fernandez C, Bojar R, Kanis R, West F, Zindaclin Clinical Study Group. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. J Dermatolog Treat. 2005;16:213–8.

    Article  CAS  PubMed  Google Scholar 

  111. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203:135–40.

    Article  CAS  PubMed  Google Scholar 

  112. Feucht CL, Allen BS, Chalker DK, Smith JG Jr. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol. 1980;3:483–91.

    Article  CAS  PubMed  Google Scholar 

  113. Habbema L, Koopmans B, Menke HE, Doornweerd S, De Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol. 1989;121(4):497–502.

    Article  CAS  PubMed  Google Scholar 

  114. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007;21:311–9.

    Article  CAS  PubMed  Google Scholar 

  115. Michaëlsson G. Oral zinc in acne. Acta Derm Venereol Suppl (Stockh). 1980;Suppl 89:87–93.

    Google Scholar 

  116. Michaëlsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol. 1977;97:561–6.

    Article  PubMed  Google Scholar 

  117. Michaëlsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol. 1977;113:31–6.

    Article  PubMed  Google Scholar 

  118. Papageorgious P, Chu A. Chloroxylenol and zinc oxide containing cream in the treatment of acne vulgaris. A double-bling randomized, controlled trial. Clin Exp Dermatol. 2000;113:31–6.

    Google Scholar 

  119. Schachner L, Pestana A, Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulations. J Am Acad Dermatol. 1990;22:489–95.

    Article  CAS  PubMed  Google Scholar 

  120. Sharquie KE, Noaimi AA, Al-Salih MM. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. Saudi Med J. 2008;29:1757–61.

    PubMed  Google Scholar 

  121. Dreno B, Blouin E. Acne, pregnant women and zinc salts: a literature review. Ann Dermatol Venereol. 2008;135(1):7–33.

    Article  Google Scholar 

  122. Akhavan A, Bershad S. Topical acne drugs. Am J Clin Dermatol. 2003;4:473–92.

    Article  PubMed  Google Scholar 

  123. Del Rosso J. The use of sodium sulfacetamide 10%/sulfur 5% emollient foam in the treatment of acne. J Clin Aesthet Dermatol. 2009;2(8):26–9.

    PubMed  PubMed Central  Google Scholar 

  124. Amr N, Abdel-Rahim H. The effect of chromium supplementation on PCOS in adolescents. J Pediatr Adolesc Gynecol. 2015;28(2):114–8.

    Article  PubMed  Google Scholar 

  125. Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A. The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double blind, placebo-controlled trial. Biol Trace Elem Res. 2016;172(1):71–8.

    Article  CAS  Google Scholar 

  126. Razavi M, Jamilian M, Kashan Z. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016;48(3):185–90.

    Article  CAS  PubMed  Google Scholar 

  127. Carretero M. Clay minerals and their beneficial effect upon human health. A review. Appl Clay Sci. 2002;21:155–63.

    Article  CAS  Google Scholar 

  128. Park S, Lee C, Lee M. Antibacterial effect of minerals from ores indigenous to Korea. J Environ Biol. 2009;30:151–4.

    PubMed  Google Scholar 

  129. Ma’or Z, Henis Y, Alon Y, Orlov E, Sørensen KB, Oren A. Antimicrobial properties of Dead Sea black mineral mud. Int J Dermatol. 2006;45:504–11.

    Article  PubMed  Google Scholar 

  130. Meier L, Stange R, Michalsen A, Uehleke B. Clay jojoba oil facial mask for lesioned skin and mild acne – results of a prospective, observational pilot study. Forsch Komplementmed. 2012;19(2):75–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, University of California, Irvine Medical Center, Orange, CA, USA

    Justin W. Marson

  2. Department of Dermatology, Rutgers Robert Wood Johnson, Piscataway, NJ, USA

    Hilary E. Baldwin

Authors
  1. Justin W. Marson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hilary E. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hilary E. Baldwin .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Reena N. Rupani

  2. Department of Dermatology & Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Peter A. Lio

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marson, J.W., Baldwin, H.E. (2021). Vitamins and Minerals in the Treatment of Acne Vulgaris. In: Rupani, R.N., Lio, P.A. (eds) Integrative Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-58954-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-58954-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-58953-0

  • Online ISBN: 978-3-030-58954-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation